Kyle Mikson

Stock Analyst at Canaccord Genuity

(0)
# 4905
Out of 5,380 analysts
103
Total ratings
Success rate
Average return
23 Stocks
Name Action PT Current % Upside Ratings Updated
ILMN Illumina
Maintains: Hold
87 99
91.49 8.21% 11 Jun 11, 2025
AKYA Akoya Biosciences
Maintains: Hold
2 2
1.24 -12.9% 5 May 19, 2025
GRAL GRAIL
Maintains: Strong Buy
32 43
43.92 -2.09% 2 May 14, 2025
BDSX Biodesix
Maintains: Buy
3 2
n/a n/a 4 May 14, 2025
XGN Exagen
Maintains: Strong Buy
7 8
7.01 14.12% 3 May 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
15 12
5.88 104.08% 6 May 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
18 15
10.88 37.87% 8 May 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
42 37
19.16 93.11% 4 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
60 65
49.98 30.05% 7 May 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
170 150
123.32 21.63% 3 Apr 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
3 3
1.2 150% 8 Apr 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
180 195
171.99 13.38% 8 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
3 3
1.2 150% 4 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
2 1
1.88 -46.81% 3 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
95 75
51.15 46.63% 9 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
3 5
n/a n/a 3 Jul 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
26
n/a n/a 2 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 2
n/a n/a 4 Nov 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
3
n/a n/a 4 Sep 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
3 2
0.77 159.74% 2 Aug 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
50
0.6 8100% 1 Mar 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
19
3.71 412.13% 1 Jan 29, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
150
n/a n/a 1 Jan 29, 2021